BioInvent International AB (publ) (FRA:BIX0)
Germany flag Germany · Delayed Price · Currency is EUR
2.995
+0.135 (4.72%)
Last updated: Jan 28, 2026, 12:28 PM CET

FRA:BIX0 Income Statement

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
244.8544.6971.46326.1319.38147.37
Revenue Growth (YoY)
533.73%-37.47%-78.09%1582.45%-86.85%57.21%
Gross Profit
244.8544.6971.46326.1319.38147.37
Selling, General & Admin
71.2558.351.6150.7539.4432.16
Research & Development
521.26457.73390.43325.93258.34191.42
Other Operating Expenses
0.67-0.1-0.02-0.08-0.23-1.25
Operating Expenses
593.18515.93442.02376.6297.55222.33
Operating Income
-348.33-471.25-370.56-50.47-278.17-74.96
Interest Expense
-0.56-0.56-0.64-0.65-0.52-0.34
Interest & Investment Income
24.7442.0940.619.070.260.03
Currency Exchange Gain (Loss)
0.470.470.49-0.45-0.03-1.07
EBT Excluding Unusual Items
-323.68-429.24-330.1-42.5-278.44-76.33
Pretax Income
-323.68-429.24-330.1-42.5-278.44-76.33
Income Tax Expense
0.260.140.2---
Net Income
-323.94-429.38-330.3-42.5-278.44-76.33
Net Income to Common
-323.94-429.38-330.3-42.5-278.44-76.33
Shares Outstanding (Basic)
666666625429
Shares Outstanding (Diluted)
666666625429
Shares Change (YoY)
-0.14%0.06%6.90%13.59%88.61%58.29%
EPS (Basic)
-4.93-6.53-5.02-0.69-5.14-2.66
EPS (Diluted)
-4.93-6.53-5.02-0.69-5.14-2.66
Free Cash Flow
-262.35-390.5-355-53.6-259.1-69.32
Free Cash Flow Per Share
-3.99-5.93-5.40-0.87-4.78-2.41
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-142.26%-1054.58%-518.54%-15.48%-1435.02%-50.86%
Profit Margin
-132.30%-960.87%-462.22%-13.03%-1436.46%-51.80%
Free Cash Flow Margin
-107.15%-873.88%-496.77%-16.44%-1336.68%-47.04%
EBITDA
-336.5-460.01-361.29-41.91-269.79-68.86
EBITDA Margin
-137.43%---12.85%--46.72%
D&A For EBITDA
11.8411.249.268.568.376.1
EBIT
-348.33-471.25-370.56-50.47-278.17-74.96
EBIT Margin
-142.26%---15.48%--50.86%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.